These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


48 related items for PubMed ID: 21334893

  • 21. A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41.
    Fujii G, Horvath S, Woodward S, Eiserling F, Eisenberg D.
    Protein Sci; 1992 Nov; 1(11):1454-64. PubMed ID: 1303764
    [Abstract] [Full Text] [Related]

  • 22. High-throughput screening method of inhibitors that block the interaction between 2 helical regions of HIV-1 gp41.
    Jin BS, Lee WK, Ahn K, Lee MK, Yu YG.
    J Biomol Screen; 2005 Feb; 10(1):13-9. PubMed ID: 15695339
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
    Chen SS, Lee SF, Wang CT.
    J Virol; 2001 Oct; 75(20):9925-38. PubMed ID: 11559825
    [Abstract] [Full Text] [Related]

  • 25. Computational study of bindings of olive leaf extract (OLE) to HIV-1 fusion protein gp41.
    Bao J, Zhang DW, Zhang JZ, Huang PL, Huang PL, Lee-Huang S.
    FEBS Lett; 2007 Jun 12; 581(14):2737-42. PubMed ID: 17537437
    [Abstract] [Full Text] [Related]

  • 26. Inter-chain acyl transfer reaction in a peptide six-helical bundle: a chemical method for regulating the interaction between peptides or proteins.
    Bai Y, Xue H, Ling Y, Cheng M, Cai L, Liu K.
    Chem Commun (Camb); 2012 May 07; 48(36):4320-2. PubMed ID: 22451895
    [Abstract] [Full Text] [Related]

  • 27. Prediction and validation of HIV-1 gp41 ecto-transmembrane domain post-fusion trimeric structure using molecular modeling.
    Gorai B, Das S, Maiti PK.
    J Biomol Struct Dyn; 2020 Jun 07; 38(9):2592-2603. PubMed ID: 31232193
    [Abstract] [Full Text] [Related]

  • 28. Interaction between HIV gp41 fusion peptide and T cell receptor: putting the puzzle pieces back together.
    Sigalov AB.
    FASEB J; 2007 Jun 07; 21(8):1633-4; author reply 1635. PubMed ID: 17538030
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Paramagnetic relaxation assisted docking of a small indole compound in the HIV-1 gp41 hydrophobic pocket.
    Gochin M, Zhou G, Phillips AH.
    ACS Chem Biol; 2011 Mar 18; 6(3):267-74. PubMed ID: 21155611
    [Abstract] [Full Text] [Related]

  • 32. Lysozyme: A Natural Product with Multiple and Useful Antiviral Properties.
    Bergamo A, Sava G.
    Molecules; 2024 Jan 30; 29(3):. PubMed ID: 38338396
    [Abstract] [Full Text] [Related]

  • 33. The Impact of Processing and Extraction Methods on the Allergenicity of Targeted Protein Quantification as Well as Bioactive Peptides Derived from Egg.
    Mostashari P, Marszałek K, Aliyeva A, Mousavi Khaneghah A.
    Molecules; 2023 Mar 15; 28(6):. PubMed ID: 36985630
    [Abstract] [Full Text] [Related]

  • 34. Functional Properties and Extraction Techniques of Chicken Egg White Proteins.
    Li Z, Huang X, Tang Q, Ma M, Jin Y, Sheng L.
    Foods; 2022 Aug 12; 11(16):. PubMed ID: 36010434
    [Abstract] [Full Text] [Related]

  • 35. RNAi screening identifies a new Toll from shrimp Litopenaeus vannamei that restricts WSSV infection through activating Dorsal to induce antimicrobial peptides.
    Li H, Yin B, Wang S, Fu Q, Xiao B, Lǚ K, He J, Li C.
    PLoS Pathog; 2018 Sep 12; 14(9):e1007109. PubMed ID: 30256850
    [Abstract] [Full Text] [Related]

  • 36. Exhaustive search and solvated interaction energy (SIE) for virtual screening and affinity prediction.
    Sulea T, Hogues H, Purisima EO.
    J Comput Aided Mol Des; 2012 May 12; 26(5):617-33. PubMed ID: 22198519
    [Abstract] [Full Text] [Related]

  • 37. Computational study of bindings of HL9, a nonapeptide fragment of human lysozyme, to HIV-1 fusion protein gp41.
    Hartono YD, Lee AN, Lee-Huang S, Zhang D.
    Bioorg Med Chem Lett; 2011 Mar 15; 21(6):1607-11. PubMed ID: 21334893
    [Abstract] [Full Text] [Related]

  • 38. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E, Hummer G, Bewley CA, Clore GM.
    J Med Chem; 2005 Apr 21; 48(8):3036-44. PubMed ID: 15828842
    [Abstract] [Full Text] [Related]

  • 39. Computational study of bindings of HK20 Fab and D5 Fab to HIV-1 gp41.
    Hartono YD, Lazim R, Yip YM, Zhang D.
    Bioorg Med Chem Lett; 2012 Feb 15; 22(4):1695-700. PubMed ID: 22260771
    [Abstract] [Full Text] [Related]

  • 40. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
    Gallo SA, Sackett K, Rawat SS, Shai Y, Blumenthal R.
    J Mol Biol; 2004 Jun 25; 340(1):9-14. PubMed ID: 15184018
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 3.